175 related articles for article (PubMed ID: 12689666)
21. [Antisecretor treatment of digestive hemorrhage associated to peptic ulcer: an approximation to the available evidence].
Bustamante Baléna M; Ponce García J
Rev Clin Esp; 2004 Mar; 204(3):161-8. PubMed ID: 15025985
[No Abstract] [Full Text] [Related]
22. [Treatment of duodenal ulcer with pantoprazole. A multicenter study].
Fric P; Huslarová A; Dítĕ P; Jirásek V; Roth Z; Svoboda J; Drazná E; Dufek V; Dvorák M; Kunovská M; Münzová H; Pelech T; Petrtýl J; Zádorová Z; Zavoral M
Cas Lek Cesk; 1996 Dec; 135(23):758-61. PubMed ID: 9005122
[TBL] [Abstract][Full Text] [Related]
23. Long-term therapy with pantoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment.
Brunner G; Harke U
Aliment Pharmacol Ther; 1994; 8 Suppl 1():59-64. PubMed ID: 8180296
[TBL] [Abstract][Full Text] [Related]
24. [Prevention of stress hemorrhage in an internal medicine intensive care station: sucralfate versus ranitidine].
Laggner AN; Lenz K; Graninger W; Gremmel F; Grimm G; Base W; Schneeweiss B; Sertl K
Anaesthesist; 1988 Nov; 37(11):704-10. PubMed ID: 3063134
[TBL] [Abstract][Full Text] [Related]
25. Pantoprazole: a new proton pump inhibitor.
Jungnickel PW
Clin Ther; 2000 Nov; 22(11):1268-93. PubMed ID: 11117653
[TBL] [Abstract][Full Text] [Related]
26. [Intravenous 3-day Helicobacter pylori eradication therapy is highly effective in patients with bleeding peptic ulcer].
Ruiz Gómez FA; Sánchez Serrano FJ; Martínez Egea A; García Del Castillo G; Sánchez Cuenca J; Coronas Planas M
Gastroenterol Hepatol; 2002; 25(6):383-6. PubMed ID: 12069699
[TBL] [Abstract][Full Text] [Related]
27. A review of treatment of duodenal and gastric ulcers--pantoprazole vs. omeprazole.
Schepp W; Rehner M; Witzel L
Aliment Pharmacol Ther; 1994; 8 Suppl 1():53-7. PubMed ID: 8180295
[TBL] [Abstract][Full Text] [Related]
28. [Evaluation of the effectiveness of pantoprazole and ranitidine in the treatment of duodenal ulcer. Result of an international multicenter study].
Papp J; Döbrönte Z; Juhász L; Lonovics J
Orv Hetil; 1997 Nov; 138(45):2863-6. PubMed ID: 9432635
[TBL] [Abstract][Full Text] [Related]
29. Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer. A randomized controlled trial.
Prod'hom G; Leuenberger P; Koerfer J; Blum A; Chiolero R; Schaller MD; Perret C; Spinnler O; Blondel J; Siegrist H; Saghafi L; Blanc D; Francioli P
Ann Intern Med; 1994 Apr; 120(8):653-62. PubMed ID: 8135449
[TBL] [Abstract][Full Text] [Related]
30. [H2 receptor antagonists and proton pump inhibitors: principles and rules of use].
Bardou M
Rev Prat; 2001 Apr; 51(7):789-95. PubMed ID: 11387678
[No Abstract] [Full Text] [Related]
31. Potential uses of intravenous proton pump inhibitors to control gastric acid secretion.
Metz DC
Digestion; 2000; 62(2-3):73-81. PubMed ID: 11025353
[TBL] [Abstract][Full Text] [Related]
32. Less acid + less bleeding = better outcomes and more money!
Enns R
Can J Gastroenterol; 2004 Dec; 18(12):747-8; discussion 748. PubMed ID: 15605140
[No Abstract] [Full Text] [Related]
33. Utility of proton pump inhibitors in the treatment of gastrointestinal hemorrhage.
Martin RA
Conn Med; 2004 Aug; 68(7):435-8. PubMed ID: 15384242
[TBL] [Abstract][Full Text] [Related]
34. Two-week course of pantoprazole combined with 1 week of amoxycillin and clarithromycin is effective in Helicobacter pylori eradication and duodenal ulcer healing.
Louw JA; van Rensburg CJ; Hanslo D; Grundlings HD; Girdwood AH; Marks IN
Aliment Pharmacol Ther; 1998 Jun; 12(6):545-50. PubMed ID: 9678814
[TBL] [Abstract][Full Text] [Related]
35. [Proton pump inhibitors in acute ulcer bleeding--what is evident?].
Bohle W; Zoller WG
Dtsch Med Wochenschr; 2000 Dec; 125(51-52):1571-4. PubMed ID: 11199449
[No Abstract] [Full Text] [Related]
36. [Do other proton pump blockers have advantages over Antra (omeprazole)?].
Creutzfeldt W
Internist (Berl); 1996 Sep; 37(9):936-7. PubMed ID: 8964689
[No Abstract] [Full Text] [Related]
37. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.
Kantorova I; Svoboda P; Scheer P; Doubek J; Rehorkova D; Bosakova H; Ochmann J
Hepatogastroenterology; 2004; 51(57):757-61. PubMed ID: 15143910
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
Hatlebakk JG; Berstad A
Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
[TBL] [Abstract][Full Text] [Related]
39. Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders.
Cheer SM; Prakash A; Faulds D; Lamb HM
Drugs; 2003; 63(1):101-33. PubMed ID: 12487624
[TBL] [Abstract][Full Text] [Related]
40. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.
Lin PC; Chang CH; Hsu PI; Tseng PL; Huang YB
Crit Care Med; 2010 Apr; 38(4):1197-205. PubMed ID: 20173630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
